Publications

May 2023
Case

Legacy Partners

By: Royce Yudkoff and Richard S. Ruback

Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021. The company, based in Sacramento CA, was a compounding pharmacy serving Total Parenteral Nutrition ("TPN") patients nationwide.... View Details

Keywords: Acquisition; Growth and Development Strategy; Competitive Strategy; Business or Company Management; Pharmaceutical Industry

Known for his autocratic and direct management style, Revson built Revlon into the second largest cosmetics company in the U.S. Revson's unique talent of grasping the female psyche, bolstered by his fiercely competitive nature, allowed... View Details

Keywords: Personal Care & Home Products

February 2024
Teaching Note

Compass Pathways: Pioneering Psychedelic Treatment

By: Tiona Zuzul

Teaching Note for HBS Case No. 724-412. View Details

Keywords: Commercialization; Corporate Strategy; Competitive Strategy; Product Launch; Health Care and Treatment; Pharmaceutical Industry; Europe; United States; United Kingdom

Fast Answer

Pharmaceuticals: Pipeline

where can I find pharmaceuticals pipeline data? In addition to the following sources, we suggest that you also check company’s website for latest pipeline info. You may begin with: Bloomberg - It is Drug Profiles allows to screen by... View Details

December 2014 (Revised October 2017)
Case

Social Business at Novartis: Arogya Parivar

By: Michael E. Porter, Mark R. Kramer and David Lane

Late in 2013, Novartis CEO Joseph Jimenez was considering whether or how to deepen the company's investment in Arogya Parivar, its profitable program that sold Novartis medicines in rural India while expanding access to medicine and health information to millions of... View Details

Keywords: Shared Value; India; Kenya; Vietnam; Novartis; Arogya Parivar; Social Business; Multinational Firms and Management; Competitive Advantage; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Viet Nam; Kenya; India

19 Sep 2017
First Look

First Look at New Research and Ideas, September 19

pharmaceutical drugs, such as those initiated by Turing Pharmaceuticals under CEO Martin Shkreli, had recently brought media attention to this issue. Baum believed it would be relatively easy for Imprimis to... View Details

Keywords: Sean Silverthorne

February 2000 (Revised June 2003)
Case

Pepcid AC: Racing to the OTC Market

By: Charles King III, Alvin J. Silk, Ernst R. Berndt and Lisa R. Klein

Pepcid management must decide whether to risk all in a race to be first in the over-the-counter market with a new heartburn remedy. View Details

Keywords: Competitive Advantage; Product Positioning; Markets; Research; Marketing Strategy; Product Development; Decision Choices and Conditions; Pharmaceutical Industry

September 2010
Teaching Note

Alnylam Pharmaceuticals: Building Value from the IP Estate (TN)

By: Willy C. Shih

Teaching Note for 611009. View Details

Keywords: Value; Patents; Corporate Strategy; Competition; Research and Development; Lawsuits and Litigation; Pharmaceutical Industry; United States

October 1992 (Revised September 1993)
Case

Nopane Advertising Strategy

By: David E. Bell

Nopane is a proprietary drug that sells in much of the United States. It faces substantial competition. The brand manager is undertaking an experiment to determine whether ad copy should be emotional-based or rational-based. The data and associated regression results... View Details

Keywords: Competition; Intellectual Property; Advertising; Health Care and Treatment; Brands and Branding; Product Marketing; Pharmaceutical Industry; United States

October 2009 (Revised July 2013)
Case

Gilead Sciences, Inc.: Access Program

By: V. Kasturi Rangan and Katharine Lee

Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients... View Details

Keywords: Health Care and Treatment; Emerging Markets; Product; Sales; Competitive Strategy; Pharmaceutical Industry; Pharmaceutical Industry

15 Dec 2024
News

After Ozempic

these drugs, known as GLP-1 agonists, amounts to so much more than media buzz. In just a few years, they have ignited a wave of change that has transformed Novo Nordisk into Europe’s most valuable public company. The seismic shift is on track to continue reshaping the... View Details

Keywords: Jen McFarland Flint; Illustrations by Pete Ryan; Ambulatory Health Care Services; Health, Social Assistance

27 Jun 2005
Research & Ideas

The Potential Downside of Win-Win

pharmaceutical firm B creates a drug that treats the same ailment and prepares to bring the drug to market. According to best estimates, this new competition will reduce the price of A's product to $2.55 per... View Details

Keywords: by Max H. Bazerman

January 1991 (Revised August 1992)
Case

Race to Develop Human Insulin

Describes the race to develop human insulin. View Details

Keywords: Competition; Health Disorders; Pharmaceutical Industry